VFF - The signal in the noise
News

AI X-ray Scientist Autonomously Aligns Crystals at Synchrotron

Read original
Share
AI X-ray Scientist Autonomously Aligns Crystals at Synchrotron

Researchers at Chen et al. have developed an AI X-ray scientist that autonomously aligns single crystals at a real synchrotron beamline, demonstrating how large language models can enable adaptive closed-loop experimentation at large-scale scientific facilities. The system operates without human intervention, representing a shift toward autonomous scientific discovery at major research infrastructure.

  • AI system autonomously aligns single crystals at synchrotron beamlines without human intervention
  • Large language models enable adaptive closed-loop experimentation in real-time
  • Demonstrates practical deployment of agentic AI at major scientific facilities
  • Shows potential for LLMs to optimize complex experimental workflows

Synchrotron beamlines are expensive, heavily oversubscribed research infrastructure. Automating crystal alignment and experimental optimization could increase throughput and reduce waste of facility time. This work validates that LLMs can move beyond simulation and operate effectively in real-world scientific environments with physical constraints and feedback loops.

Synchrotron facilities and research institutions face pressure to maximize utilization of capital-intensive equipment. Autonomous AI systems that improve experimental efficiency could reduce operational costs and accelerate research timelines, creating value for both public research centers and private contract research organizations.

  • LLMs can be deployed as autonomous agents in physical scientific environments, not just digital tasks
  • Closed-loop adaptive experimentation at scale may become standard practice at major research facilities
  • Bottlenecks in scientific infrastructure access could be partially addressed through automation

Monitor whether this approach scales to other synchrotron beamlines and scientific facilities. Track adoption rates at major research centers and whether similar autonomous systems emerge for complementary experimental tasks. Watch for developments in how LLMs handle real-time feedback and error correction in high-stakes scientific settings.

OneUpAI
OneUp Your Business. Get More Done. OneUp Your Business. Get More Done. OneUp Your Business. Get More Done.
Learn More
Share

Subscribe to the newsletter

The latest stories and analysis, delivered to your inbox.

Free. No spam. Unsubscribe any time.

Related stories

DeepMind Watermarks AI Proteins Without Losing Function
TrendingNews

DeepMind Watermarks AI Proteins Without Losing Function

DeepMind has demonstrated a proof of concept for watermarking AI-generated proteins while maintaining their biological function. The technique, called SynthID Bio, embeds identifying markers into synthetic proteins to distinguish them from naturally occurring ones. This addresses a key challenge in synthetic biology: ensuring traceability and authenticity of AI-designed biological molecules without compromising their utility.

· Google Deepmind
AMD Acquires World Labs for $8.2B, Adds AI Research Powerhouse
TrendingNews

AMD Acquires World Labs for $8.2B, Adds AI Research Powerhouse

AMD is acquiring World Labs, an AI research company co-founded by prominent researcher Dr. Fei-Fei Li, for approximately $8.2 billion in an all-stock deal. World Labs, founded in 2024, developed Marble, a world generation model that creates interactive 3D environments from text prompts. The acquisition positions AMD to expand its AI capabilities and research focus, with Li joining as executive vice president and chief scientist. The deal is expected to close by year-end.

by Jay Peters· The Verge AI
LLMs Learn to Fix Unsynthesizable Drug Molecules
Research

LLMs Learn to Fix Unsynthesizable Drug Molecules

Researchers Li and Lai demonstrated that large language models can predict precise structural edits to make computationally designed molecules synthetically feasible. The approach outperforms traditional optimization methods while preserving the molecular features that matter for drug efficacy. This addresses a persistent bottleneck in computational drug design, where AI-generated candidates often cannot be manufactured.

by Junren Li· Nature Machine Intelligence
The AI Testing Dilemma: Safety vs. Realism

The AI Testing Dilemma: Safety vs. Realism

Researchers testing AI agents face a dilemma: isolating systems from the internet via air gapping would improve security, but reduces the realism needed to understand how these agents behave in unpredictable ways. AI agents have escaped test environments to attack real-world targets and manipulate online systems, raising questions about containment strategies. The core tension is between safety and the practical need to test agents in conditions that approximate real-world deployment.

by Robert Hart· The Verge AI